Biological E. Limited has appointed Anumeha Srivastava as the new Chief Executive Officer of its Digital Health Joint Venture, signaling a strategic move towards integrating AI and digital innovation in healthcare.
In her role, Srivastava will guide the joint venture's strategic initiatives, focusing on the application of advanced technologies to enhance healthcare solutions. Her appointment follows a notable six-year tenure at Qure.ai, where she was instrumental in driving global commercial growth and expanding AI-driven healthcare offerings. As Chief Business Officer, she bolstered partnerships with healthcare providers and improved clinical outcomes through AI solutions.
Srivastava's background includes significant roles in client success and operations at Qure.ai, where she facilitated the adoption of AI in clinical workflows across various regions. She also has experience in healthcare operations from her time at Max Healthcare and has contributed to social impact initiatives through program management at The Ganga Trust.
With a strong foundation in both clinical care and business, along with an MBA from the Indian School of Business, Srivastava is well-equipped to lead Biological E.'s efforts in developing innovative, technology-driven healthcare solutions. This appointment underscores the company’s commitment to advancing healthcare through digital transformation.